Takeda Pharmaceutical Co Ltd

(TKPHF)

By |

Profile

Takeda Pharmaceutical Co Ltd is Japan's largest pharmaceutical company, with revenue of JPY 3.3 trillion in 2019. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 70% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Contact Information

Website: www.takeda.com
Email: takeda.ir.contact@takeda.com
Main Phone: +81 332782306
Address: 1-1, Nihonbashi-Honcho 2-Chome
Address 2: Chuo-ku
City / Town: Tokyo
Country: JPN
Postal Code: 103-8668

Issuer Information

Exchange: OTO
CEO: Christophe Weber
Employees: 47495
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Takeda Pharmaceutical Co Ltd is Japan's largest pharmaceutical company, with revenue of JPY 3.3 trillion in 2019. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 70% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Contact Information

Website: www.takeda.com
Email: takeda.ir.contact@takeda.com
Main Phone: +81 332782306
Address: 1-1, Nihonbashi-Honcho 2-Chome
Address 2: Chuo-ku
City / Town: Tokyo
Country: JPN
Postal Code: 103-8668

Issuer Information

Exchange: OTO
CEO: Christophe Weber
Employees: 47495
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 34.49 $ 0.23 (0.66%)
Last Price 34.49 Change $ 0.23 Change % 0.66 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 34.80 High 35.00 Low 34.49 Prev Close 34.26
Last Trade Volume 1,675 52 Wk Hi 42.00 52 Wk Low 25.21
Market Cap 53.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,557,765,596.00 EPS (TTM) 1.39 PE Ratio 1,936.40 Exchange OTCPK